| # | Drug | Count |
|---|---|---|
| 0 | FARICIMAB | 66 |
| 1 | AFLIBERCEPT | 55 |
| 2 | BROLUCIZUMAB | 43 |
| 3 | PEGCETACOPLAN | 31 |
| 4 | DEXAMETHASONE | 19 |
| 5 | ATROPINE SULFATE | 12 |
| 6 | BEVACIZUMAB | 12 |
| 7 | PREDNISOLONE | 12 |
| 8 | PREDNISOLONE ORAL | 12 |
| 9 | PREDNISOLONE ORAL SOLUTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANIBIZUMAB-NUNA | 1 | 0.0213 |
| 1 | PEGCETACOPLAN | 31 | 0.0163 |
| 2 | BROLUCIZUMAB | 43 | 0.0118 |
| 3 | AFLIBERCEPT-AYYH | 1 | 0.0099 |
| 4 | DIFLUPREDNATE OPHTHALMIC | 8 | 0.0090 |
| 5 | AVACINCAPTAD PEGOL | 3 | 0.0085 |
| 6 | FARICIMAB | 66 | 0.0074 |
| 7 | FLUORESCEIN SODIUM | 1 | 0.0032 |
| 8 | DIFLUPREDNATE | 9 | 0.0023 |
| 9 | AFLIBERCEPT | 55 | 0.0018 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 5 | 0.0011 |
| 1 | Anticholinergic [EPC] | 13 | 0.0008 |
| 2 | Complement Inhibitor [EPC] | 31 | 0.0006 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 68 | 0.0004 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 10 | 0.0003 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 8 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 9 | Anti-anginal [EPC] | 2 | 0.0002 |